MIAMI, March 22, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces 2017 annual results.
The Company announced over $20 million in net revenues, a 10% increase over 2016, and positive earnings of approximately $50,000. This represents the second consecutive year that the company has accomplished net positive earnings in its audited financial statements. Cost of goods sold increased relative to sales due to increases in DIR and other PBM fees implemented in 2017 as compared to 2016. Prescriptions filled increased 5% to over 225,000 during 2017. The company also filled over $2.7 million worth of prescriptions (Not Included in Net Revenues) for 340B entities during 2017, generating fees to the pharmacy of approximately $113,000, which is over a 400% increase over 2016.
The annual report showcased the continued development of the Company’s portfolio of healthcare services. Noted within the Management Discussions are the key accomplishments of 2017 which include uplisting to OTCQB, the addition of independent board members, tele-pharmacy platform development, 12 non-resident state licenses and a 5 star pharmacy rating. The performance of the pharmacy has been recognized by Outcomes, the leading MTM platform, and Humana’s Quality Network for reaching performance metrics in key areas.
The Company has declared ambitious plans during the 2018 fiscal year starting with the announcement of a planned acquisition of a pharmacy in Palm Beach County. In addition to year-over-year sales growth and profitability, the Company plans to expand into the development of proprietary products and technologies that will further diversify the Company’s healthcare service model. Though there are many risks disclosed in the annual report that stem from changes in the industry and government regulation to unforeseen market turndowns, the Company has a positive outlook on the coming year.
“Filing our second year of audited financial statements 10 days early has a profound significance for me personally,” stated S. Parikh Mars, CEO. “In all the years, I have worked with Progressive Care both inside and out, we were not able to accomplish this goal until now. I could not be prouder of the accounting team we have put together this year and a staff that knows how to do things right every day. I hope that we are delivering the transparency our shareholders expect and the results that motivate them to keep believing in this company.”
Get connected and stay in touch with us on social media:
About Progressive Care
Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.